LPCN
Lipocine Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.39
−1.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 44.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.90x
- Price / sales
- 12.53x
- Price / cash flow
- -1.76x
Enterprise value
- Enterprise value
- -$3.6M
- EV / sales
- -2.30x
- EV / EBITDA
- 0.31x
- EV / EBIT
- 0.29x
- Market cap
- $19.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026